Advisor Net Financial, Inc Guardant Health, Inc. Transaction History

Advisor Net Financial, Inc

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 19, 2024	SELL	$21.58 - $29.5 $64 - $88	-3 Reduced 50.0%	3 $0
Q3 2023 Oct 12, 2023	BUY	$25.8 - $39.97 $154 - $239	6 New	6 $0
Q1 2023 Apr 28, 2023	BUY	$22.92 - $33.76 $229 - $337	10 Added 200.0%	15 $0
Q4 2022 Jan 13, 2023	SELL	$25.44 - $59.78 $127 - $298	-5 Reduced 50.0%	5 $0
Q3 2022 Oct 04, 2022	SELL	$43.66 - $61.0 $2,837 - $3,965	-65 Reduced 86.67%	10 $1,000
Q2 2022 Jul 07, 2022	SELL	$28.82 - $77.35 $7,781 - $20,884	-270 Reduced 78.26%	75 $3,000
Q1 2022 Apr 14, 2022	SELL	$48.25 - $100.49 $19,300 - $40,196	-400 Reduced 53.69%	345 $23,000
Q4 2021 Jan 19, 2022	SELL	$88.71 - $120.43 $798 - $1,083	-9 Reduced 1.19%	745 $75,000
Q3 2021 Oct 15, 2021	SELL	$98.77 - $132.17 $15,901 - $21,279	-161 Reduced 17.6%	754 $94,000
Q2 2021 Jul 06, 2021	SELL	$109.77 - $165.68 $7,135 - $10,769	-65 Reduced 6.63%	915 $114,000
Q1 2021 Apr 14, 2021	SELL	$127.04 - $179.1 $4,446 - $6,268	-35 Reduced 3.45%	980 $150,000
Q4 2020 Feb 04, 2021	SELL	$99.96 - $135.93 $12,495 - $16,991	-125 Reduced 10.96%	1,015 $131,000
Q3 2020 Nov 06, 2020	SELL	$80.32 - $111.8 $54,858 - $76,359	-683 Reduced 37.47%	1,140 $127,000
Q2 2020 Aug 26, 2020	SELL	$60.49 - $97.5 $9,194 - $14,820	-152 Reduced 7.7%	1,823 $148,000
Q1 2020 May 14, 2020	BUY	$59.04 - $88.81 $103,024 - $154,973	1,745 Added 758.7%	1,975 $137,000
Q4 2019 Feb 12, 2020	BUY	$59.49 - $82.78 $7,138 - $9,933	120 Added 109.09%	230 $18,000
Q2 2019 Jul 15, 2019	BUY	$63.94 - $91.11 $7,033 - $10,022	110 New	110 $9,000

323

127M

844K

2.38M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.75B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of Advisor Net Financial, Inc, based on Form 13F filings with the SEC.

Stay updated on Advisor Net Financial, Inc with notifications on news.